Cefpodoxime Proxetil
Cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below.
United States
$32
per month
India
$1
per month
You save
−96%save $31/mo · 96% cheaper
528.1K US scripts/yr$16.4M potential annual savings$17M US spend/yr
Drag to rotate · 3D structureC21H27N5O9S2
SMILES: CC(C)OC(=O)OC(C)OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\OC)/C3=CSC(=N3)N)COC
Compare the price
US price$41per month
India priceNot availableno India data yet
You save—add India price to compare
Based on 30 EAs per month. US $1.36 per unit — India price not available for this variant.
Total over 1 periodIndia price not availableUS total $41
The bigger picture
Cefpodoxime Proxetil is filled about 528.1K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$17M
If sourced from India
$617.9K
Potential annual savings
$16.4M
−96%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.